Prabha Sridevan, the former chairperson of India’s Intellectual Property Appellate Board, says that just as Indian companies must obey American laws when selling their wares in the US, international pharmaceutical companies must similarly comply with Indian laws if they wish to do business in the world’s second most populous market
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
IP firm leaders share why they remain positive in the face of falling patent applications from US filers, and how they are meeting a rising demand from China
Lawyers at Simmons & Simmons look ahead to a UK Supreme Court hearing in which the court will consider whether English courts can determine FRAND terms when the licence is offered by an intermediary rather than an SEP owner
Law firms are expanding their ITC practices to account for the venue’s growing popularity, and some are seeing an opportunity to collaborate with M&A teams